🔎 Trials Near Me

Home › Soft Tissue Sarcoma › District of Columbia › Washington

Soft Tissue Sarcoma clinical trials in Washington, DC

12 studies for Soft Tissue Sarcoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

RecruitingPhase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 3 to 39 · All sexes · Updated Sep 29, 2026 · NCT06865664

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

RecruitingObservational studyHealthy volunteers welcome
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
4 Weeks · All sexes · Updated Sep 28, 2026 · NCT01109394

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

RecruitingPhase 1
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi away
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05711615

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi away
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Recruiting
  • Sibley Memorial Hospital, Washington D.C.
Up to age 39 · All sexes · Updated Jul 13, 2026 · NCT06796543

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

RecruitingPhase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 to 120 · All sexes · Updated May 19, 2026 · NCT06503146

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RecruitingPhase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

Pre-operative Hypofractionated Proton Therapy

Recruiting
  • Sibley Memorial Hospital, Washington D.C.
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT05917301

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

RecruitingPhase 1/2
  • Children's National Hospital, Washington D.C.
Ages 2 to 30 · All sexes · Updated Feb 3, 2026 · NCT05734066

Pediatric Radiation Therapy Registry

RecruitingObservational study
  • Sibley Memorial Hospital, Washington D.C.
Ages 0 to 26 · All sexes · Updated Nov 5, 2025 · NCT07129317

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RecruitingPhase 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975

About Soft Tissue Sarcoma

Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available

More about Soft Tissue Sarcoma on MedlinePlus

Soft Tissue Sarcoma trials in other cities

Other studies in Washington

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.